 |
|
Regular multivitamin use near time of conception significantly reduces preeclampsia risk
July 27, 2006Women who are considering becoming pregnant may significantly reduce their risk of developing a common life-threatening complication called preeclampsia by taking a multivitamin supplement regularly three months before conception and during the first trimester of pregnancy. This finding is being reported in a University of Pittsburgh study available online now through an "advance access" feature of the American Journal of Epidemiology. The paper is scheduled for publication in the Sept. 1 print issue of the journal.
Overall, women who used multivitamins regularly showed a 45 percent reduction in preeclampsia risk, according to the study. However, results were even more remarkable for women who were not overweight prior to pregnancy.
"Our data show that women who are not overweight before pregnancy and who used multivitamins at least once a week before conception and in the first three months of pregnancy reduced their risk of preeclampsia by a striking 72 percent compared to those who didn't take a multivitamin during this time period," said Lisa Bodnar, Ph.D., M.P.H., R.D., assistant professor of epidemiology at the University of Pittsburgh Graduate School of Public Health (GSPH). "At this time, multivitamin use makes little apparent difference in preeclampsia rates for women who are overweight before pregnancy. Even so, the results suggest that regular multivitamin use in the pre-pregnancy period may help to prevent preeclampsia."
Also known as toxemia, preeclampsia affects about 7 percent of first pregnancies and is a leading cause of premature delivery and maternal and fetal death. Signs of preeclampsia include high blood pressure, protein in the urine and swelling of the hands and feet. Untreated, the condition may progress to the far more serious eclampsia, which can lead to seizures, coma and death.
Preeclampsia is more prevalent in the developing world, where it accounts for up to 80 percent of maternal deaths. And while treatment is more readily available in developed countries, preeclampsia remains the leading cause of maternal death. Infants born to mothers with preeclampsia have a risk of mortality five times greater than those born to women with normal pregnancies. In the United States alone, nearly 15 percent of preterm deliveries are a result of preeclampsia.
Dr. Bodnar and her colleagues evaluated data from 1,835 women who were enrolled in the University of Pittsburgh's Pregnancy Exposures and Preeclampsia Prevention Study between 1997 and 2001. Overall, the prevalence of preeclampsia was 4.4 percent for non-multivitamin users and 3.8 percent for those who used multivitamins, with the most significant differences being noted among women who had a body mass index (a common body weight measure) of less than 25. Most authorities define overweight at a BMI of 25 and obesity as a BMI of 30 or above.
Because multivitamins contain many nutrients, it is difficult to know the exact mechanism by which the risk of preeclampsia is reduced, noted Dr. Bodnar, who also is an assistant investigator at the university-affiliated Magee-Womens Research Institute (MWRI). Other recent studies have shown limited benefits - and some risk - associated with large doses of vitamins C and E in women at high risk of preeclampsia. "However, the study does show further evidence that nutrition is relevant for the prevention of preeclampsia," she said.
Although Dr. Bodnar and her colleagues tried to adjust for possible complicating factors such as smoking, exercise habits, fruit- and vegetable-intake, demographic and other socioeconomic factors, it is possible that the study findings could be attributed to other differences among multivitamin supplement users and nonusers that investigators did not identify. In addition, the analysis depended on self-reporting of multivitamin use rather than a random assignment of supplement use. Even so, the association between multivitamin use and diminished risk of preeclampsia strongly continues inasmuch as adjustments are possible.
"Preeclampsia is a potentially devastating condition for mother and baby," observed James M. Roberts, M.D., director of the Magee-Womens Research Institute and senior author of the paper. "It may be that taking a multivitamin prior to conception positively influences embryonic implantation, which is a physiologic process known to be abnormal in preeclampsia. More study is needed to clarify these findings."
Researchers are unsure of the reasons why multivitamin use appears to have no benefit to preeclampsia risk in overweight women, Dr. Bodnar said. "It may be that typical multivitamins, which contain low nutrient doses, may not be adequate to overcome the metabolic challenges associated with the development of preeclampsia along with being overweight and pregnant," she added. "But again, more study is needed to test these ideas."
University of Pittsburgh Medical Center
Also known as toxemia, preeclampsia affects about 7 percent of first pregnancies and is a leading cause of premature delivery and maternal and fetal death. Signs of preeclampsia include high blood pressure, protein in the urine and swelling of the hands and feet. Untreated, the condition may progress to the far more serious eclampsia, which can lead to seizures, coma and death.
Preeclampsia is more prevalent in the developing world, where it accounts for up to 80 percent of maternal deaths. And while treatment is more readily available in developed countries, preeclampsia remains the leading cause of maternal death. Infants born to mothers with preeclampsia have a risk of mortality five times greater than those born to women with normal pregnancies. In the United States alone, nearly 15 percent of preterm deliveries are a result of preeclampsia.
Dr. Bodnar and her colleagues evaluated data from 1,835 women who were enrolled in the University of Pittsburgh's Pregnancy Exposures and Preeclampsia Prevention Study between 1997 and 2001. Overall, the prevalence of preeclampsia was 4.4 percent for non-multivitamin users and 3.8 percent for those who used multivitamins, with the most significant differences being noted among women who had a body mass index (a common body weight measure) of less than 25. Most authorities define overweight at a BMI of 25 and obesity as a BMI of 30 or above.
Because multivitamins contain many nutrients, it is difficult to know the exact mechanism by which the risk of preeclampsia is reduced, noted Dr. Bodnar, who also is an assistant investigator at the university-affiliated Magee-Womens Research Institute (MWRI). Other recent studies have shown limited benefits - and some risk - associated with large doses of vitamins C and E in women at high risk of preeclampsia. "However, the study does show further evidence that nutrition is relevant for the prevention of preeclampsia," she said.
Although Dr. Bodnar and her colleagues tried to adjust for possible complicating factors such as smoking, exercise habits, fruit- and vegetable-intake, demographic and other socioeconomic factors, it is possible that the study findings could be attributed to other differences among multivitamin supplement users and nonusers that investigators did not identify. In addition, the analysis depended on self-reporting of multivitamin use rather than a random assignment of supplement use. Even so, the association between multivitamin use and diminished risk of preeclampsia strongly continues inasmuch as adjustments are possible.
"Preeclampsia is a potentially devastating condition for mother and baby," observed James M. Roberts, M.D., director of the Magee-Womens Research Institute and senior author of the paper. "It may be that taking a multivitamin prior to conception positively influences embryonic implantation, which is a physiologic process known to be abnormal in preeclampsia. More study is needed to clarify these findings."
Researchers are unsure of the reasons why multivitamin use appears to have no benefit to preeclampsia risk in overweight women, Dr. Bodnar said. "It may be that typical multivitamins, which contain low nutrient doses, may not be adequate to overcome the metabolic challenges associated with the development of preeclampsia along with being overweight and pregnant," she added. "But again, more study is needed to test these ideas."
University of Pittsburgh Medical Center
Preeclampsia News and Current Preeclampsia Events RSSCommon treatment to delay labor decreases preterm infants' risk for cerebral palsy
Intravenous magnesium sulfate supplementation before preterm delivery cuts the risk for handicapping cerebral palsy in half, according to research led by University of Alabama at Birmingham (UAB) obstetrician Dwight Rouse, M.D., and published in the Aug. 28 issue of The New England Journal of Medicine.
Maternal deaths following cesarean delivery can be reduced
Maternal death rates have remained constant in the United States for many decades. Are there any improvements in health care that could reduce these rates further?
Stretching exercises may reduce risk of pre-eclampsia during pregnancy
Stretching exercises may be more effective at reducing the risk of preeclampsia than walking is for pregnant women who have already experienced the condition and who do not follow a workout routine, according to researchers at the University of North Carolina at Chapel Hill School of Nursing.
A new gene trigger for pregnancy disorder identified
The COMT gene - known already for its role in schizophrenia - has been found to play a role in preeclampsia, according to a report in today's advance on-line issue of Nature.
Mothers' high normal blood sugar levels place infants at risk for birth problems
Pregnant women with blood sugar levels in the higher range of normal-but not high enough to be considered diabetes-are more likely than women with lower blood sugar levels to give birth to babies at risk for many of the same problems seen in babies born to women with diabetes during pregnancy, according to a study funded in large part by the National Institutes of Health.
New finding may help explain development of preeclampsia
In a study of pregnant women, those with pregnancy-induced high blood pressure were found to have higher levels of a peptide that raises blood pressure in the pieces of tissue linking mother and fetus, according to researchers at Wake Forest University Baptist Medical Center.
Stop eating for two: obese moms-to-be should gain less weight than currently recommended
Severely obese women should lose weight during pregnancy, while obese women who are pregnant should gain less weight than currently recommended, a Saint Louis University study finds.
Researchers test old drug with new hopes for pre-eclampsia cure
Researchers at the University of Texas Medical Branch at Galveston are trying to determine whether a drug already available to heart patients can also be used to delay delivery in expectant mothers with severe preeclampsia.
Low vitamin D during pregnancy linked to preeclampsia
Vitamin D deficiency early in pregnancy is associated with a five-fold increased risk of preeclampsia.
Disparities in infant mortality not related to race, study finds
The cause of low birth weights among African-American women has more to do with racism than with race, according to a report by an associate professor of pediatrics at the University of Illinois at Chicago.
More Preeclampsia News Articles
 | Pre-eclampsia: Etiology and Clinical Practice Pre-eclampsia is one of the leading causes of death and disability in mothers and babies. Over four million women worldwide will develop the disorder every year. This book, written by an international team of experts, focuses on both the scientific basis of pre-eclampsia and its management. The basic science section contains up-to-date reviews of the most exciting research developments in... |
 | Baby Nathan by Denise Davis Denise Davis, MSW, LSW, was born in Hammond, Indiana, in 1972. She was raised by a single mother since the age of ten when her father died in a tragic accident. Focusing on her academics, she worked hard during her school years and earned a master’s degree in social work from Loyola University in 2002. She currently works in Merrillville, Indiana, providing psychotherapy to children and... |
| Pre-eclampsia: The Facts: The Hidden Threat to Pregnancy (Oxford Medical Publications) by Chris Redman, Isabel Walker Pre-eclampsia is the development of hypertension during pregnancy and the most common and the most potentially serious complication of pregnancy. It affects one out of every ten pregnancies, yet there is little known about the disease. This work informs pregnant women, family practitioners, and midwives of this usually symptomless, but often dangerous condition. It includes several illuminating... | |
| The Insulin Time-bomb: Supplement, A New Dawn by Stoakes Ian | |
| EPH-gestosis (preeclampsia): Etiology, prevention, treatment (Publication - Organisation Gestosis Press) by William B Patterson | |
 | Recurrent Miscarriage And Pre-eclampsia: The Roles Played By The Immune System And Antioxidants by Rhoda Wilson Examines the role of antioxidants & of the immune system in pathogenesis of pre-eclamsia & recurrent... |
| Management of severe pre-eclampsia and eclampsia | |
| Pre-eclampsia: Current Perspectives on Management by Philip N. Baker, John Kingdom | |
| A study in pre-eclampsia and eclampsia with special reference to protein stabilization treatment: From the Department of Obstetrics, School of Medicine, ... and the Elizabeth Steel Magee Hospital by Boyd Harden | |
| Preeclamptic and eclamptic toxemia of pregnancy by Lewis Dexter |
| © 2008 BrightSurf.com |